Tci Wealth Advisors, Inc. Fibrogen Inc Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$15.95 - $25.18 $7,911 - $12,489	496 New	496 $9,000
Q2 2022 Jul 19, 2022	SELL	$7.94 - $12.96 $3,922 - $6,402	-494 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$9.93 - $15.39 $1,777 - $2,754	179 Added 56.83%	494 $7,000
Q3 2021 Oct 29, 2021	BUY	$10.18 - $26.64 $407 - $1,065	40 Added 14.55%	315 $3,000
Q2 2021 Aug 02, 2021	BUY	$18.57 - $35.68 $5,106 - $9,812	275 New	275 $7,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.